Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the effect of FFR (Fractional flow reserve) guided Percutaneous Coronary Intervention in coronary tandem lesions.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Percutaneous Transluminal Coronary Angioplasty

NCT number NCT02797561
Study type Observational
Source Asan Medical Center
Contact Seung-jung Park, MD
Email sjpark@amc.seoul.kr
Status Recruiting
Phase
Start date July 25, 2016
Completion date December 31, 2027

See also
  Status Clinical Trial Phase
Completed NCT00767663 - Persantin Preceding Elective PCI Phase 4
Withdrawn NCT02784418 - The SHINE-CTO Trial N/A
Active, not recruiting NCT02042300 - XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice
Recruiting NCT03209414 - Frailty Syndrome in Daily Practice of Interventional Cardiology Ward
Active, not recruiting NCT02939872 - Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events Phase 4
Recruiting NCT05972070 - Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
Terminated NCT02831205 - Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease Phase 4
Not yet recruiting NCT04455568 - Establish a Telecare Model of Acute Coronary Syndrome Patient With Heart Stent Implantation by a Non-invasive Wearable Device and Artificial Intelligence Cloud to Reducing Medical Adverse Events.
Recruiting NCT01186133 - Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
Recruiting NCT02497014 - The European Bifurcation Club Left Main Study N/A
Terminated NCT02831218 - Quantitative Coronary Angiography Versus Imaging GUIDancE for Bioresorbable Vascular Scaffold Implantation N/A